Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma

Weber, JS; Levinson, BA; Laino, AS; Pavlick, AC; Woods, DM

Woods, DM (通讯作者)，Univ Colorado, Div Med Oncol, Dept Med, Anschutz Med Campus,12801 E 17th Ave,MS 8117, Aurora, CO 80045 USA.

MELANOMA RESEARCH, 2022; 32 (5): 324

Abstract

Checkpoint immunotherapies (CPIs) have improved outcomes for metastatic melanoma patients, with objective response rates to combination ipilimumab and......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索